Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Acquisitions: 2015-2021

Historic Acquisitions for Aytu Biopharma (AYTU) over the last 4 years, with Jun 2021 value amounting to $15.7 million.

  • Aytu Biopharma's Acquisitions was N/A to $5.5 million in Q2 2020 from the same period last year, while for Jun 2020 it was $532,393, marking a year-over-year change of. This contributed to the annual value of $15.7 million for FY2021, which is 168.75% up from last year.
  • According to the latest figures from FY2021, Aytu Biopharma's Acquisitions is $15.7 million, which was up 168.75% from $5.8 million recorded in FY2020.
  • Over the past 5 years, Aytu Biopharma's Acquisitions peaked at $15.7 million during FY2021, and registered a low of $613,309 during FY2017.
  • For the 2-year period, Aytu Biopharma's Acquisitions averaged around $10.8 million, with its median value being $10.8 million (2020).
  • Data for Aytu Biopharma's Acquisitions shows a peak YoY soared of 168.75% (in 2021) over the last 5 years.
  • Over the past 3 years, Aytu Biopharma's Acquisitions (Yearly) stood at $613,309 in 2017, then reached $5.8 million in 2020, then soared by 168.75% to $15.7 million in 2021.